Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

A Miami-based company that makes baby food sold under a Target store brand is recalling over 25,000 packages of a product ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...